The aim of this study was to evaluate the relationship between serum adiponectin levels and carotid–femoral pulse wave velocity (cfPWV) in hemodialysis (HD) patients.
Method:
Blood samples were obtained from 120 HD patients. cfPWV was measured with a validated tonometry system (SphygmoCor; AtCor Medical, West Ryde, Australia). Serum adiponectin levels were measured using a commercially available enzyme-linked immunosorbent assay kit.
Results:
By univariate linear analysis of cfPWV in HD patients, we found that diabetes (r = .281, p = .002), pre-HD body weight (r = .194, p = .033), post-HD body weight (r = .192, p = .036), waist circumference (r =.210, p = .022), and body fat mass (r = .194, p = .034) were positively correlated, whereas adiponectin level (r = −.254, p = .005) was negatively correlated with cfPWV in HD patients. Multivariate forward stepwise linear regression analysis showed that diabetes (β = .274, p = .006) and adiponectin level (β = −.215, p = .016) were independent predictors of cfPWV in HD patients. Moreover, post-HD body weight (β = −.274, p = .041), waist circumference (β = −.311, p < .001), logarithmically transformed triglyceride level (log-TG; β = −.186, p = .031), and log-glucose (β = −.225, p = .008) were negatively associated with adiponectin levels in HD patients after multivariable forward stepwise linear regression analysis.
Conclusions:
Among HD patients, serum adiponectin level was inversely associated with cfPWV level, and post-HD body weight, waist circumference, log-TG, and log-glucose were negatively associated with adiponectin level.
AbeY.MatsumaeT.EtoS.WatanabeM.ItoK.SasatomiY.…SaitoT. (2012). Total and HMW adiponectin is independently associated with B-type natriuretic peptide and anemia in chronic hemodialysis patients. Internal Medicine, 51, 3247–3252.
2.
AlbertiK. G.ZimmetP. Z.ShawJ. (2006). Metabolic syndrome—A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetes Medicine, 23, 469–480.
3.
BlacherJ.GuerinA. P.PannierB.MarchaisS. J.SafarM. E.LondonG. M. (1999). Impact of aortic stiffness on survival in end-stage renal disease. Circulation, 99, 2434–2439.
4.
BrunnerE. J.ShipleyM. J.Ahmadi-AbhariS.TabakA. G.McEnieryC. M.WilkinsonI. B.…KivimakiM. (2015). Adiposity, obesity, and arterial aging: Longitudinal study of aortic stiffness in the Whitehall II cohort. Hypertension, 66, 294–300.
5.
CardosoC. R.SallesG. F. (2016). Aortic stiffness as a surrogate endpoint to micro- and macrovascular complications in patients with Type 2 diabetes. International Journal of Molecular Science, 17, E2044.
6.
Di IorioB.NargiO.CuccinielloE.BellizziV.TorracaS.RussoD.BellasiA. (2011). Coronary artery calcification progression is associated with arterial stiffness and cardiac repolarization deterioration in hemodialysis patients. Kidney & Blood Pressure Research, 34, 180–187.
7.
El KhoudaryS. R.Barinas-MitchellE.WhiteJ.Sutton-TyrrellK.KullerL. H.CurbJ. D.…SekikawaA. (2012). Adiponectin, systolic blood pressure, and alcohol consumption are associated with more aortic stiffness progression among apparently healthy men. Atherosclerosis, 225, 475–480.
8.
El-ShafeyE. M.ShalanM. (2014). Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients. Therapeutic Apheresis and Dialysis, 18, 185–192.
9.
Freitas LimaL. C.BragaV. A.do Socorro de França SilvaM.CruzJ. C.Sousa SantosS. H.de Oliveira MonteiroM. M.BalariniC. M. (2015). Adipokines, diabetes and atherosclerosis: An inflammatory association. Frontiers of Physiology, 6, 304.
10.
GalicS.OakhillJ. S.SteinbergG. R. (2010). Adipose tissue as an endocrine organ. Molecular and Cellular Endocrinology, 316, 129–139.
11.
GeorgianosP. I.SarafidisP. A.LasaridisA. N. (2015). Arterial stiffness: A novel cardiovascular risk factor in kidney disease patients. Current Vascular Pharmacology, 13, 229–238.
12.
GhantousC. M.AzrakZ.HanacheS.Abou-KheirW.ZeidanA. (2015). Differential role of leptin and adiponectin in cardiovascular system. International Journal of Endocrinology, 2015, 534320.
13.
HoC. C.HsuB. G.YinW. Y.HoG. J.ChenY. C.LeeM. C. (2016). Serum adiponectin is a negative predictor of central arterial stiffness in kidney transplant patients. Scandinavian Journal of Clinical Laboratory Investigation, 76, 264–269.
14.
HsuB. G.ShihM. H.ChenY. C.HoG. J.LinT. Y.LeeM. C. (2015). High serum osteoprotegerin is associated with arterial stiffness in kidney transplant patients. Tohoku Journal of Experimental Medicine, 236, 247–253.
15.
KahnM. R.RobbinsM. J.KimM. C.FusterV. (2013). Management of cardiovascular disease in patients with kidney disease. Nature Reviews Cardiology, 10, 261–273.
16.
KorjianS.DaaboulY.El-GhoulB.SamadS.SalamehP.DahdahG.…BahousS. A. (2016). Change in pulse wave velocity and short-term development of cardiovascular events in the hemodialysis population. Journal of Clinical Hypertension, 18, 857–863.
17.
LeeC. J.WangJ. H.ChenY. C.ChenM. L.YangC. F.HsuB. G. (2014). Serum osteopontin level correlates with carotid-femoral pulse wave velocity in geriatric persons. Biomed Research International, 2014, 570698.
18.
LiangJ.QiuQ.GongY.LiuX.DouL.ZouC.…QiL. (2015). Adiponectin genotype, blood pressures, and arterial stiffness: The Cardiometabolic Risk in Chinese (CRC) study. Journal of Clinical Hypertension, 17, 395–400.
19.
LiuW.JiangL.ChenJ.GaoC.ZhouJ.ZhouJ.…YangJ. (2017). Association of adipokines with blood pressure, arterial elasticity and cardiac markers in dialysis patients: Cross-sectional analysis of baseline data from a cohort study. Nutrition & Metabolism, 14, 34.
20.
ManciaG.FagardR.NarkiewiczK.RedónJ.ZanchettiA.BöhmM.…ZannadF. (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension, 31, 1281–1357.
21.
MauryE.BrichardS. M. (2010). Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Molecular and Cellular Endocrinology, 314, 1–16.
22.
MiyataniM.KanehisaH.MasuoY.ItoM.FukunagaT. (2001). Validity of estimating limb muscle volume by bioelectrical impedance. Journal of Applied Physiology, 91, 386–394.
23.
NittaK.AkibaT.UchidaK.OtsuboS.OtsuboY.TakeiT.…NiheiH. (2004). Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertension Research, 27, 47–52.
24.
PalomboC.KozakovaM. (2016). Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications. Vascular Pharmacology, 77, 1–7.
25.
PetersenK. S.BlanchN.KeoghJ. B.CliftonP. M. (2015). Effect of weight loss on pulse wave velocity: Systematic review and meta-analysis. Arteriosclerosis, Thrombosis, and Vascular Biology, 35, 243–252.
26.
PrennerS. B.ChirinosJ. A. (2015). Arterial stiffness in diabetes mellitus. Atherosclerosis, 238, 370–379.
27.
PrskaloZ.BrizićI.MarkotaD.MarkotaI.BobanM.TomicM.StarcevicB. (2016). Arterial stiffness in patients with coronary artery disease: Relation with in-stent restenosis following percutaneous coronary intervention. BMC Cardiovascular Disorders, 16, 128.
28.
RobinsonB. M.AkizawaT.JagerK. J.KerrP. G.SaranR.PisoniR. L. (2016). Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: Differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet, 388, 294–306.
29.
SedaghatS.Mattace-RasoF. U.HoornE. J.UitterlindenA. G.HofmanA.IkramM. A.…DehghanA. (2015). Arterial stiffness and decline in kidney function. Clinical Journal of the American Society of Nephrology, 10, 2190–2197.
30.
ShibataR.OuchiN.OhashiK.MuroharaT. (2017). The role of adipokines in cardiovascular disease. Journal of Cardiology, 70, 329–334.
31.
SrikanthanK.FeyhA.VisweshwarH.ShapiroJ. I.SodhiK. (2016). Systematic review of metabolic syndrome biomarkers: A panel for early detection, management, and risk stratification in the West Virginian population. International Journal of Medical Sciences, 13, 25–38.
32.
TonelliM.KarumanchiS. A.ThadhaniR. (2016). Epidemiology and mechanisms of uremia-related cardiovascular disease. Circulation, 133, 518–536.
33.
TsiakouA.LiatisS.AlexiadouK.DiakoumopoulouE.MakrilakisK.TentolourisN.…KatsilambrosN. (2013). Arterial stiffness is inversely related to plasma adiponectin levels in young normotensive patients with Type 1 diabetes. Diabetes Care, 36, 734–736.
34.
VlachopoulosC.AznaouridisK.StefanadisC. (2010). Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis. Journal of American College of Cardiology, 55, 1318–1327.
35.
VlachopoulosC.XaplanterisP.AboyansV.BrodmannM.CífkováR.CosentinoF.…TownsendR. R. (2015). The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis, 241, 507–532.
36.
WangC. H.WangJ. H.LeeC. J.FangT. C.LiouH. H.HsuB. G. (2010). Fasting serum adiponectin level inversely correlates with metabolic syndrome in peritoneal dialysis patients. Blood Purification, 30, 1–7.
37.
WangJ. H.LeeC. J.ChenM. L.YangC. F.ChenY. C.HsuB. G. (2014). Association of serum osteoprotegerin levels with carotid-femoral pulse wave velocity in hypertensive patients. Journal of Clinical Hypertension, 16, 301–308.
38.
WohlfahrtP.SomersV. K.SochorO.KulloI.JeanN.Lopez-JimenezF. (2015). Influence of body fatness distribution and total lean mass on aortic stiffness in nonobese individuals. American Journal of Hypertension, 28, 401–408.
